Brokers Issue Forecasts for TScan Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:TCRX)

TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Research analysts at Wedbush issued their Q1 2025 earnings per share estimates for TScan Therapeutics in a research report issued to clients and investors on Wednesday, April 17th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings per share of ($0.26) for the quarter. Wedbush […]

Leave a Reply

Your email address will not be published.

Previous post Investors Buy Large Volume of Call Options on ProShares UltraPro Short QQQ (NASDAQ:SQQQ)
Next post Zacks Research Comments on FormFactor, Inc.’s Q1 2025 Earnings (NASDAQ:FORM)